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Background: Hyperlipidemia has been implicated as the major risk factor of cardiovascular 
diseases. The current hypothesis suggests oxidative stress as an underlying mechanism through 
which hyperlipidemia provoke degenerative diseases. The aim of this study is to investigate the 
ameliorative and antioxidant effect of camel milk on poloxamer 407 (P407) induced 
hyperlipidemia in albino rats. Methods: Thirty male wistar rats were subdivided into six 
groups (Group 1-6) with each containing five animals (n=5). Group 1 served as normal 
control, while Groups 2-6 were induced with Poloxamer 407 intra peritoneally twice a week 
for three weeks. Group 2 served as hyperlipidemic untreated, group 3 was co-administered 
with atorvastatin tablet 20mg/kg orally and groups 4, 5 and 6 were co-administered with camel 
milk at a dose of 250mg/kg, 500mg/kg and 1000mg/kg respectively via oral route. After three 
weeks, blood samples determination of Total cholesterol (TC), Triglyceride(TG), High Density 
Lipoprotein (LDL), Low Density Lipoprotein(LDL), Malondialdhyde (MDA), Catalase(CAT) 
Superoxide Dismutase(SOD) and Gluthatione Peroxidase(GPx) were carried out. Results: 
Total cholesterol was significantly (p< 0.05) decreased in group treated with camel milk at 
1000mg/kg (174.68 ±46.92 mg/dl), treatment with camel milk doses 
250mg/kg(63.57±6.34mg/dl), 500mg/kg (45.07±3.13mg/dl), 1000mg/kg (91.38±5.52mg/dl) 
significantly (p<0.05) reduced high triglyceride level induced by P407. Camel milk treated 
group at dose 250mg/kg showed significant increase in HDL (208.72±7.88 mg/dl), while 
camel milk treated groups 250mg/kg and 1000mg/kg showed significant decrease in LDL; 
(214.15±21.72mg/dl) and (114.75±42.83mg/dl) respectively. Camel milk significantly 
(p<0.05) increase in the level of SOD at 250mg/kg and 500mg/kg (9.25±0.51 U/ml and 11.04± 
1.14 U/ml) respectively, however, there was no significant (p>0.05) effect on CAT. There was 
also no significant difference in MDA between all camel milk treated groups and the normal 
control group. Conclusion: These findings highlight the ameliorative potentials of camel milk 





Cardiovascular diseases (CVD) are the leading cause of 
death for both men and women among all racial and 
ethnic groups (Smith, 2004).  It accounts for nearly 
50% of all deaths in the developed world (Thomas and 
Rich, 2007) and have also been predicted to affect 
approximately 23.6 million people globally by 2030 
(Ooi and Liong, 2010). Hyperlipidemia is a global 
pandemic and a major risk factor for cardiovascular 
diseases such as artherosclerosis, stroke, myocardial 
infarction and pancreatitis (Olorunnisola et al., 2012; 
Harikumar et al., 2013). The burden of this condition is 
very high in terms of morbidity, mortality and medical 
costs (Oguejiofor et al., 2012). Hyperlipidemia may 
result from hereditary factors or acquired from 
underlying diseases such as; type 2 diabetes mellitus, 
liver cholestasis, alcohol, nephrotic syndrome, chronic 
renal failure, hypothyroidism, cigarette smoking, drugs, 
hormone disturbances and obesity (Olorunnisola et al., 
2012; Harikumar et al., 2013; Onwe et al., 2015). 
Common features of hyperlipidemia include elevation 
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of serum total cholesterol, triglyceride, low density 
lipoprotein, very low density lipoprotein, and reduced 
high density lipoprotein (Olorunnisola et al., 2012). 
Oxidative stress has been implicated as an underlying 
mechanism through which hyperlipidemia induce tissue 
damage with several studies paying attention to the 
oxidative modification of Low Density Lipoprotein(ox-
LDL), protein glycation, glucose auto-oxidation and 
lipid peroxidation (Bansal and Jaswal 2009; 
Olorunnisola et al., 2012; Adekunle et al., 2013; Ngoc 
2015). Poloxamer 407 (P407) is a ubiquitous manmade 
surfactant and non-ionic detergent. Structurally, P407 is 
a copolymer of ethylene oxide and propylene oxide 
with a molecular weight of 12,600. P407 has unusual 
thermoreversible properties. It is a liquid at room 
temperature, while at body temperature it reassembles 
into micelles that aggregate into a gel. These 
temperature-dependent micellization and gelation 
properties have led to the widespread use of P407 in 
personal care products such as mouthwashes, 
deodorants, and skin care products and also as an 
excipient in a variety of pharmaceutical preparations 
(Dumortier et al., 2006). P407 has a major adverse 
effect, which hyperlipidemia is observed in 
experimental animals after parenteral administration 
(Johnston and Palmer 1993; Johnston 2004). 
There are several allopathic hypolipidemic drugs 
currently available; however, some of these drugs do 
not fulfill the conditions for patients’ compliance 
(Davidson and Tooth, 2004). Consumption of such 
drugs have been reported to have adverse effect such as  
hyperuricemia, diarrhea, nausea, myositis, gastric 
irritation, flushing, dry skin and abnormal liver function 
(Dhaliya et al., 2013). The search for potential 
cardiovascular protective agents from natural sources 
had been gaining universal acceptance; many studies 
are paying attention to natural products as candidates of 
hypolipidemics which are also antioxidant but have no 
side effects. These candidates are supposed to improve 
quality of life which can be impaired by conventional 
hypolipidemic agents (Bansa and Jaswal 2009; Sefi et 
al., 2010; Olorunnisola et al., 2012). Camel milk has 
been utilized since ancient times due to its therapeutic 
benefit. It is used in countries such India and Egypt in 
the treatment of wide range of diseases, some of which 
include; edema, jaundice, asthma, splenic disorders, 
anemia, hemorrhoids, diabetes and fatigue (Redwan et 
al., 2003; Chakrapany and Chandan, 2014). In ancient 
Soviet Republic, camel milk was used in sanitoria for 
the treatment of tuberculosis (Guakhar and Bernand, 
2004). The main component of the milk which has a 
major impact on its nutritional value and technological 
suitability is protein and vitamins (Gizachew et al., 
2014).However, it does not contain β-lacto globulin 
and can be easily digested by lactose-intolerant 
individuals (Gizachew et al., 2014).Camel milk does 
not form coagulum in acidic environment (Hassan and 
Bayoumi, 2010) and is reported to have  insulin 
encapsulated  in nano particles  (lipid  vesicles)  which 
make its  absorption  through  the  gastrointestinal tract  
and  entry  into circulation possible (Ajamaluddin et al., 
2012).It also contains vitamin and disease fighting 
immunoglobulins which are small  in  size,  allowing  
penetration  of  antigens and  boosting  the  
effectiveness  of  the  immune  system (Gizachew et 
al.,2014). Recent researches have shown  that camel 
milk possess hypoglycemic and anti hyperlipidemic 
properties in diabetes models (Agrawwal et al., 2002; 
Al Numair, 2010,Isa et al., 2013), antioxidant and 
hepatoprotective effect in autistic children (Al Ayadhi 
and El Amin 2013), AlCl3, Acetaminophen and CCL4 
intoxication (Al Hashem, 2009; Al Humaid, 2010; 
Alfartosi 2012; Ibrahim et al., 2017).   
To the best of our knowledge, the ameliorative effect 
camel milk on poloxamer 407-induced hyperlipidemia 
in albino rats has not been examined. Hence, the aim of 
this study is to determine the effect of camel milk on 
lipid profile and oxidative stress markers of poloxamer 
407-induced hyperlipidemia in albino rats. 
 
MATERIALS AND METHODS 
Experimental animals 
Thirty adult male wistar rats weighing 150-200g were 
obtained from the Animal House, Faculty of 
Pharmaceutical Sciences, Ahmadu Bello University, 
Zaria, Nigeria. All the rats were kept in well ventilated 
steel wire cages (5 rats per cage) with normal 
photoperiod and fed the same type of food elements 
(Vital Feeds) with access to water ad libitum. The rats 
were allowed to acclimatize under laboratory 
conditions for two weeks before commencement of the 
experiment.  
 
Collection of Camel Milk 
Milk collection was done every day from camel herds 
(Camelus dromedaries) in Kaura Namoda Farms, 
Zamfara State. It was stored in screwed bottles and 
stored in ice-cold boxes. The milk was transferred and 
refrigerated 3-5ºC (37-41ºF) at the Department of 
Pharmacology Laboratory, Ahmadu Bello University, 
Zaria. 
 
Proximate Analysis of Camel Milk 
Proximate analysis of the milk was carried out at 
National Animal Production Research Institute 
(NAPRI) and National Research Institute for Chemical 
Technology (NARICT) all in Zaria prior to 
commencement of administration. Determination of all 
constituents was based on the guidelines outlined by 
the Association of Analytical Chemist (AOAC), 
(2005). 
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Induction of Hyperlipidemia  
Poloxamer407 (Lutrol F127; BASF,Ludwigshafen, 
Germany) was utilized to induce Hyperlipidemia. Prior 
to the administration, it was dissolved in distilled water 
and refrigerated overnight to facilitate its dissolution. It 
was administered at a dose of 500mg/kg 
intraperitoneally twice a week for 3 weeks (Woo et al., 
2010). Needles and syringes used for administration 
were cooled to prevent gelation within the syringe 
during injection as described by Johnston and Palmer 
(1993). 
 
Acute Toxicity Studies of Camel Milk 
Determination of Median Lethal Dose (LD50) of camel 
milk was conducted using the method of Lorke (1983). 
The median lethal dose was found to be greater than 
5000mg/kg via oral route. 
 
Preparation of stock concentration of camel milk 
A beaker was placed on the gallen metter 
balance.10mls of the milk was weighed and was 
equivalent 10g. Hence, 1ml of the milk was equivalent 
to 1g after weighing. Stock concentration of 
1000mg/kg is equivalent to 1000mg/ml.  
 
Preparation of Standard Drug  
Atorvastatin was purchased in tablet form at strength 
20mg (Strovas Tablet 20mg/kg, Ranbaxy Laboratory 
Ltd, Paonta Sahib Distribution, Sirmour H.P. 173025, 
India). Tablets were dissolved in distilled water and 




Group 1: Normal Control animals fed with a standard 
diet and orally administered 1 ml/kg distilled water for 
21 days. Group II: Hyperlipidemic Control was 
induced with 500mg/kg of poloxamer 407 intra 
peritoneally twice a week without treatment for 3 
weeks Group III: Induced with 500mg/kg of Poloxamer 
407 intra peritoneally twice a week and treated with 
Atorvastatin tablet (ATV) orally at 20mg/kg body 
weight/day for 21 days. Groups IV: Induced with 
500mg/kg of Poloxamer 407 intra peritoneally twice a 
week and co administered with 250mg/kg of camel milk 
orally once daily for 21 days. Group V: Induced with 
500mg/kg of Poloxamer 407 intra peritoneally twice a 
week and co administered with 500mg/kg of camel 
milk orally once daily for 21 days. Group VI: Induced 
with 500mg/kg of Poloxamer 407 intra peritoneally 
twice a week and co-administered with 1000mg/kg of 
camel milk orally once daily for 21 days. 
 
Collection of Blood Samples 
At the end of the 21-day experimental period, animals 
were fasted overnight and sacrificed by cervical 
dislocation. Blood was collected via cardiac puncture 
into anticoagulant free bottles and centrifuged at 3000 
rpm for 15 minutes with the resultant sera harvested 
into plain sample bottles. 
 
Biochemical Parameters 
Serum Total Cholesterol (TC), Triglyceride (TG) and 
High Density Lipoprotein (HDL) were determined 
using Agappe Diagnostics Reagents (Agappe 
Diagnostics, Switzerland, GmbH). Low Density 
Lipoprotein (LDL) was calculated according to 
Friedewald et al., (1972). 
 
Table 1: Composition of camel milk as determined 




Lipid Peroxidation and Antioxidant Enzyme Assays 
Malondialdehyde (MDA) was assayed in the form of 
Thiobarbituric Acid Reacting Substances (TBARS) 
according to Fraga et al., (1988). Glutathione 
peroxidase (GPx) was measured using the method of 
Rotruck et al., (1973). Superoxide dismutase (SOD) 
was measured as described by Martin et al., (1987), 
while Catalase (CAT) enzyme activity was measured 
according to the method of Aebi (1984).  
 
Statistical Analysis 
Data obtained was expressed as mean (±SEM). The 
result was analysed using one way analysis of 
Variance(ANOVA), followed by Tukey’s Post hoc Test 
to compare the level of significance between groups 
using Statcato software version 0.9.12. Values of p ˂ 
0.05 were considered significant. 
 
RESULTS 
Constituents of camel milk 
The camel milk constituents as determined from 
proximate analysis are shown in table 1. Camel milk 
revealed the following constituents; ash, carbohydrates, 
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fats, fatty acids, lactic acid, nitrogen, moisture and 
tested positive to glycoside. Camel milk also proved the 
presence of vitamins A, B2, C and E at various 
wavelengths.  
 
Effect of Camel Milk on Total Cholesterol (TC) and 
Triglyceride (TG) of P407 Induced Hyperlipidemic 
wistar Rats 
 Total Cholesterol (TC)  
The total cholesterol level in rats within the normal 
control group is (74.28 ±5.70 mg/dl) as shown in figure 
1. After induction with P407, cholesterol level in the 
hyperlipidemic untreated group was significantly 
(p<0.05) higher (727.24 ±126.59 mg/dl) than the 
normal control group. Treatment with camel milk at  
1000  mg/kg  orally resulted in significant(p<0.05) 
reduction  in  cholesterol  level  (174.68  ±46.92 mg/dl) 
more than when atorvastatin 20 mg/kg (215.39 ±32.68 
mg/dl) is given.  
 
 
Fig. 1: Effect of Camel Milk on Total Cholesterol and 
Triglyceride on P407 Induced Hyperlipidemic Wistar Rats. 
Results are expressed as mean ± standard error of mean, n = 
5.  Group I: Normal control Group II : P407(500mg/kg) 
Group III P407(500mg/kg) + AT(20mg/kg), Group IV: 
P407(500mg/kg) + CM(1000mg/kg),Group V: 
P407(500mg/kg) +CM500mg/kg, Group VI: P407(500mg/k) 
+ CM (250mg/kg).Values with superscripts are statistically 
significant (p<0.05);  a = when compared to Group I, b = 





There was significant increase (p < 0.05) in triglyceride 
of the hyperlipidemic untreated group (203.16 ± 
27.64mg/dl) when compared to the normal control 
group (38.97±1.51mg/dl). Treatment with atorvastatin 
at a dose of 20mg/kg (38.74±2.97mg/dl) and at all 
camel milk doses 250mg/kg (63.57±6.34mg/dl), 
500mg/kg(45.07±3.13mg/dl), 1000mg/kg (91.38 
±5.52mg/dl) significantly (p<0.05) reduced high 
triglyceride level induced by P407.  
 
 
Fig. 2: Effect of Camel Milk on High Density Lipoprotein 
and Low Density Lipoprotein on P407 Induced 
Hyperlipidemic Wistar Rats. Results are expressed as mean ± 
standard error of mean, n = 5. Group I: Normal control 
Group II: P407(500mg/kg) Group III P407(500mg/kg) + AT 
(20mg/kg), Group IV: P407(500mg/kg) + CM(1000mg/kg), 
Group V: P407(500mg/kg) +CM500mg/kg, Group VI: 
P407(500mg/k) + CM (250mg/kg).Values with superscripts 
are statistically significant (P<0.05);  a = when compared to 
Group I, b = when compared to Group II, c= when compared 
to Group III. 
 
 
Effect of Camel Milk on High Density Lipoporotei 
n(HDL) and Low Density Lipoporotein (LDL) of P407 
Induced Hyperlipidemic wistar Rats: 
 
High Density Lipoporotein (HDL)  
The HDL level in the normal control group is 35.97 ± 
2.43mg/dl as shown in figure 2. After induction, the 
hyperlipidemic untreated group showed significant 
(p< 0.05) increase (279.45± 10.33mg/dl) compared 
to the normal control group. There was significant 
(p< 0.05) increase between the camel milk treatment 
group 250mg/kg (208.72±7.88 mg/dl) and the normal 
control group.  
 
Low Density Lipoprotein (LDL) 
The LDL level in rats within the hyperlipidemic 
untreated group showed significant increase (p<0.05) 
(414.09±25.96mg/dl) compared with the normal control 
group (29.74±5.85mg/dl). There was significant (p< 
0.05) difference between camel milk treated group 
250mg/kg (214.15±21.72mg/dl), 1000mg/kg 
(114.75±42.83mg/dl) and atorvastatin treated group 
(177.59±30.36mg/dl) compared to the hyperlipidemic 
untreated group.  
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Table 2: Effect of Camel Milk on Oxidative Stress Biomarkers of Poloxamer 407 Induced Hyperlipidemic Wistar 
Rats 
Group  CAT (U/ml)  SOD (U/ml)  GPx (U/ml)        MDA(nMols/ml)  
(n=5) 
Group   I 7.25 ± 0.69   11.23 ± 0.97  31.97 ± 3.70  119.23±20.70  
Group II 3.26 ± 0.47a  3.25 ± 1.05a   25.32 ±0.60  180.18±18.66a 
Group III 5.59 ± 1.64  5.68 ± 0.65a  31.03 ± 6.00  173.27±14.07a 
Group IV 3.04 ± 0.36a  9.25 ± 0.51bc       32.81 ± 5.18  130.00 ± 9.05c 
Group V 3.62 ± 0.72a  11.04 ± 1.14bc        47.60 ± 5.60  125.82 ± 9.77c  
Group VI 3.88 ± 0.33a  7.58 ± 1.70        36.82 ± 3.85  165.82 ±16.72 
 
 
Effect of Camel Milk on Serum Oxidative Stress 
Biomarkers of P407 Induced Hyperlipidemic wistar 
Rats 
Catalase (CAT) 
The effect of P407 on catalase activity showed a 
significant (p<0.05) decrease in the hyperlipidemic 
untreated group when compared to the normal control 
group as shown in table 2. The mean value of the 
hyperlipidemic untreated group (3.26 ± 0.47 U/ml) is 
lower normal when compared to the normal control 
group (7.25 ± 0.69U/ml). The mean values of all camel 
milk treated groups (250mg/kg, 500mg/kg and 
1000mg/kg) (3.04 ± 0.363U/ml 3.62 ± 0.72U/ml and 
3.88 ±0.33U/ml) are lower when compared to normal 
control group (p<0.05).  
 
Superoxide Dismutase (SOD) 
There was a significant  (p<0.05)  decrease  in  
superoxide  dismutase  of the  hyperlipidemic untreated 
group when compared to normal control group as 
shown in Table 2. Camel milk treated groups 250mg/kg 
and 500mg/kg (9.25±0.51 U/ml and 11.04± 1.14 U/ml) 
showed significant increase (p<0.05) when compared to 
hyperlipidemic untreated and atorvastatin treated 
groups respectively. There was no significant 
difference (P>0.05) between the normal control group 
and all camel milk treatment groups (9.25±0.51 U/ml, 
11.04± 1.14 U/ml and 7.58±1.70 U/ml). 
 
Gluthathione Peroxidase (GPx) 
There was no significant (p>0.05) difference between 
all the groups as shown in Table 2. 
 
Malondialdehyde (MDA) 
Serum Malondialdehyde level showed significant 
(p<0.05) increase in the hyperlipidemic untreated group 
(180.18±18.66nMols/ml) compared to normal control 
group (119.23±0.97 nMols/ml) (Table 2). Camel milk 
treated groups 250mg/kg, 500mg/kg and 1000mg/kg 
(130.00±9.05nMols/ml 125.82±9.77nMols/ml 
and165.82 ±16.72nMols/ml) respectively had no 
significant (p>0.05) difference when compared to the 
normal control group.  
 
DISCUSSION 
Hyperlipidemia progresses with alteration in the serum 
lipids profile making it important risk factor in many 
degenerative diseases (Kolawole et al., 2012; Sodipio 
et al., 2012). Lipid abnormality can be qualitative or 
quantitative (Oguejiofor et al., 2012). Quantitatively, it 
is due to elevated Total Cholesterol (TC), elevated Low 
Density Lipoprotein Cholesterol (LDL-C) elevated 
Triglyceride (TG) and reduced High Density 
Lipoprotein Cholesterol (HDL-C) levels occurring 
singly or in combinations. Qualitatively it implies 
changes in composition of LDL-C which includes small 
dense LDL-C increased TG content or increased 
electronegativity of LDL-C (Oguejiofor et al., 2012). 
Poloxamer 407 induced hyperlipidemia is associated 
with alterations in the activities of 3-hydroxy-3- 
methylglutaryl-CoA (HMG-CoA) reductase, lecithin 
cholesterol acyltransferase (LCAT), cholesteryl ester 
transfer protein (CETP), hepatic lipase (HL) and 
lipoprotein lipase (LPL) (Johnston and Plamer, 1993). 
P-407 directly inhibits heparin releasable fraction of 
LPL and HL with indirect increase in the biological 
activities of CETP and LCAT (Johnston and Plamer, 
1993). In the present study, rats treated with P-407 
were characterized by higher serum lipid profiles after 
repeated administration for 3 weeks. The increase in the 
level of TC, TG, HDL and LDL in the hyperlipidemic 
untreated group is consistent with the works of 
Korolenko et al., (2012), Korolenko et al., (2013) and 
Mithun et al., (2011). However, camel milk lowered 
serum TC, TG, LDL and increased HDL which is in 
agreement with the works of Al Hashem, (2009), Al 
Numair, (2010), Abd el aziz et al., (2012), Isa et al., 
(2013) and Ibrahim et al., (2017). Camel milk contains 
vitamins C and E (table 1), both of which have been 
reported to lower TC TG and LDL (Badr et al., 2011). 
The hypolipidemic activity of the camel milk in the 
p407 model may be due to inhibition of HMG-CoA 
reductase, stimulation of Cholesterol-7-alpha-
Camel milk and poloxamer-induced hyperlipidemia 
 
63            J. Afr. Ass. Physiol. Sci. 5 (1): July, 2017                                                                                  Zuberu et al  
 
hydroxylase which converts cholesterol into bile acids, 
or inhibition of cholesterol absorption from the 
intestine due to formation of complexes with 
compounds such as glycosides (table 1) (James et al., 
2010). Ibrahim et al., (2017) proposed that the 
reduction in TC and LDL cholesterol by camel milk 
could as well be due to the increase in inhibitory 
activity on lecithin cholesterol acyl transferase enzyme, 
increase binding of LDL to LDL receptor and/or 
through an indirect effect on thyroid hormones. Al 
Numair (2010) and Abd el aziz et al., (2012) concluded 
from their findings that significant decrease in TG by 
camel milk is due to the presence of insulin like protein 
and high amount of zinc (Al Numair, 2010). Insulin 
attenuates lipoprotein lipase activity which in turn 
decreases the level of TG (Arkilla et al., 2001). 
Moreover, it was previously shown that zinc 
supplementation facilitates insulin secretory activity in 
pancreatic islets of the ob/ob mouse (Begin-Heicket et 
al., 1985). Extracellular ATP and zinc activate multiple 
P2X purinergic receptor channels expressed by islet 
beta-cells to potentiate insulin secretion (Richards et 
al., 2008). On the other hand, an elevated level of HDL 
is probably the result of attenuation of hepatic lipase by 
camel milk. Elevated level of HDL exerts an anti-
atherogenic effect by counteracting LDL oxidation and 
facilitating the translocation of cholesterol from 
peripheral tissue such as arterial walls to the liver for 
catabolism (Yoon et al., 2008). HDL also transports 
cholesterol and cholesterol esters from the peripheral 
tissues and cells back to the liver, where cholesterol is 
metabolized into bile acids. This pathway plays a very 
important role in reducing the level of cholesterol in the 
blood and peripheral tissues and in inhibiting the 
formation of atherosclerotic plaque in the aorta (Kim et 
al., 2008; Imafidon 2010). This significant 
hypolipidemic effect of camel milk shows its potential 
ability to reduce  atherosclerosis  risk.  
Measurement of thiobarbituric acid (TBARS) 
has been used as indicators to determine lipid 
peroxidation and oxidative stress in vitro and in vivo 
(Fraga et al., 1988; Beltowski et al., 2000). Lipid 
peroxidation is initiated by peroxidative decomposition 
of membrane polyunsaturated fatty acids by free 
radicals, leading to their transformation and 
fragmentation to alkanes and reactive aldehyde 
compounds such as MDA and 4 hydoxy-2,3- nonenals 
(HNE) (Olorunnisola et al., 2012; Ngoc 2015). 
Evaluation of the effect of poloxamer 407 in 
experimental rats showed a significant increase in 
MDA levels in serum. The observed increase in lipid 
peroxidation is consistent with several experimental 
studies which have shown that hyperlipidemia leads to 
increase lipid peroxidation (Dutta and Bishayi, 2009; 
Olorunnisola et al., 2012 Woo et al., 2012; Ngoc 
2015). Co-adminstration of poloxamer 407 induced 
hyperlipidemic rats with camel milk at doses of 
250mg/kg, 500mg/kg significantly reduced MDA 
concentration when compared to atorvastatin. The 
result of our findings agrees with the work of Al 
Hashem (2009) and Al Fartosi et al., (2012). The 
ability of camel milk to inhibit the process of lipid 
peroxidation in vivo may be due to the free radical 
scavenging properties of its vitamins and zinc as 
reported by al Ibrahim et al., (2017). In addition to 
vitamins C and E, camel milk from our proximate 
analysis also contains vitamins A and B2 (table 1); all 
of which possess antioxidant properties (Al Hashem, 
2009; Al Humaid 2010, Badr et al., 2011; Dawud  et 
al., 2012; Ibrahim et al.,  2017). Vitamins C and E 
work synergistically to quench the activities of free 
radicals and also regenerates the reduced form of 
vitamin E (Chuong et al., 2008). Vitamin E also 
inhibits the process of lipid peroxidation through its 
radical chain-breaking antioxidant properties 
(Bjelakovic et al., 2007). Vitamin C is a scavenger of 
free oxygen radicals which are toxic by product of 
many metabolic processes. The presence of zinc in 
camel milk may have induced the production of 
metallothionein, an effective scavenger of hydroxyl 
radicals (Sahin and Kucuk, 2003). Serum antioxidant 
enzymes (SOD and CAT) activities were significantly 
decreased in rats induced with P407 compared to 
normal control group. The decrease in the activities of 
these enzymes, could be attributed to their exhaustive 
utilization in quenching the free radicals generated due 
to the hyperlipidemia (Ma et al., 2011) as manifested 
by the high level of lipid peroxidation. Co-
administration of camel milk to P407 induced 
hyperlipidemic rats at doses 250mg/kg, and 500 mg/kg 
significantly increased the level of SOD which is 
consistent with the findings of Al Hashem (2009) and 
El Said et al., (2010) but differs with respect to reduced 
catalase activity. This difference may be attributed to 
the percentage composition of each elements and 
geographical location where the milk is found. Camel 
milk showed tendencies to increase in GPx activity 
possibly due its magnesium content (Kamal et al., 
2007; Al Hashem, 2009; Ibrahim et al., 2017). 
Magnesium in addition to glycine, γ-glutamyl cysteine 
and ATP are required for the biosynthesis of 
glutathione synthetase and thus glutathione (Virginia et 
al., 1971). Our results indicate that camel milk had a 
free radical scavenging activity which probably 
protects organs protection from hyperlipidemia. 
 
CONCLUSION 
Poloxamer 407 had adverse hyperlipidemic effect in on 
male Wistar rats. Our results  demonstrated  that  
poloxamer 407 is  capable  of inducing marked 
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alterations in biochemical parameters and  oxidative  
damage,  and  inhibiting  the  function  of antioxidant 
enzymes. Consequently, attention should be paid to the 
use of poloxamer in gels, mouth washes and drugs 
excipient. Camel milk administration during poloxamer 
407 induced hyperlipidemia minimized P407-
associated hazards in male albino rats. Therefore, 
drinking camel milk could be beneficial in alleviating 
some health hazards associated with hyperlipidemia. 
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